1. No category

Laboratory
Routine Applications
Lovelace, USA
NERC, USA
Fraunhofer, Germany
TNO, The Netherlands
ISPRA, Italy
Inveresk, Scotland
Austria Tabak, Austria
A B F , Germany
Oakridge Laboratories, USA
Battelle, NW, USA
IITRI, USA
Will labs, USA
Huntingdon Life Sciences, UK
Labstat, Canada
CIT, France
CDC, Atlanta (Ashley)
Research (Development and Validation
of Assays with Cigarette Smoke)
University of Nebraska (Steven Rennard)
University of California, Davis (Hanspeter
Witschi, Kent Pinkerton, Carroll Cross)
University of Siena, Italy (?)
University of Genova, Italy (Silvio de Flora)
Gary Gairola, consultant
University of British Columbia, Vancouver
(Joanne Wright, A n d y Churg, James Hogg)
State University New York (Terry Gordon)
OurCVD connections in Germany,
Belgium
and The Netherlands
University of Minnesota, Minneapolis
(Stephen Hecht)
University in Baton Rouge, Louisiana
(Arthur Penn)
University of Munich (Elmar Richter)
C:\TEMP\LABORATORY3.DOC
http://legacy.library.ucsf.edu/tid/ocv96g00/pdf
Capabilities
inhalation toxicology
Inhalation toxicology of complex mixtures
inhalation toxicology,
clinical studies for inhalants
inhalation toxicology
development and validation of methods for
cigarette ingredient testing in the EU
inhalation toxicology,
rodents to primates
chemical smoke composition,
toxicological testing
chemical smoke composition,
exposure field testing,
biomarkers (dose, effect)
chemical and physical smoke properties,
field exposure determinations
chemical smoke composition,
inhalation toxicology
inhalation toxicology, in vitro studies
inhalation toxicology
inhalation toxicology,
rodents to primates
Smoke chemistry
preclinical studies for regulatory purposes
Smoke chemistry
Biomarkers of COPD in humans
Inhalation toxicology, oxidant stress in vitro
Inhalation
Inhalation
Inhalation
Inhalation
toxicology (emphysema)
toxicology
toxicology
toxicology (COPD)
Inhalation toxicology (carcinogenesis)
CVD Biomarkers in humans
Exposure analysis (TSNA, PAH, Acrolein)
Inhalation toxicology (atherosclerosis,
acrolein monitoring)
Exposure analysis (TSNA, aromatic amines,
DNA adducts)
2505910288
University of Mainz (Hans-Anton Lehr)
University of California, Berkeley (Steven
Parmley et al.)
National Center for Toxicological Research,
Nebraska (Fred Kadlubar)
Studies in Humans
Peter Barnes, NHLI, Imperial College,
London, UK
William MacNee, University of Edinburgh,
UK
Robert Stockley, Queen Elizabeth Hospital,
Birmingham, UK
Goran Lofdahl, University Hospital, Lund,
Sweden
Inhalation toxicology (CVD, eg.,
microcirculation)
Inhalation toxicology (CVD, eg.,
atherosclerosis, myocardial infarct)
Exposure analysis (aromatic amines, etc.)
biomarker, early biological effect (EBE),
airway inflammation
biomarker, EBE, (ox. stress)
biomarker, EBE, (airway inflammation)
biomarker, EBE, (airway inflammation)
01
00
i
C:\TEMP\LABORATORY3.DOC
http://legacy.library.ucsf.edu/tid/ocv96g00/pdf
Nebraska (FredKadlubar)
—Mvsfcssu.??
Etc. etc. etc.
C/T-,
ftfci
Exposure analysis (aromatic amines, etc.)
-<_
KcKVui,
1
'
( ^ ^ t - i
rf
fot^/"
|rs ^ u>
/= S5 e
(e*-
p
F^G*)
^ k A - u ein^ t ^^^
(j w iM-i h K 4 "^ W^ Lu tt ^(
X {A
\ y <%,
I7 •>«-». 7
10
en
o
tn
(D
.&
O
ro
<o
o
^
jiw
IA^ -U\A>& u 5
http://legacy.library.ucsf.edu/tid/ocv96g00/pdf